These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 37863894)

  • 1. Macrophage polarization and metabolism in atherosclerosis.
    Hou P; Fang J; Liu Z; Shi Y; Agostini M; Bernassola F; Bove P; Candi E; Rovella V; Sica G; Sun Q; Wang Y; Scimeca M; Federici M; Mauriello A; Melino G
    Cell Death Dis; 2023 Oct; 14(10):691. PubMed ID: 37863894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage Plasticity and Atherosclerosis Therapy.
    Lin P; Ji HH; Li YJ; Guo SD
    Front Mol Biosci; 2021; 8():679797. PubMed ID: 34026849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage phenotypes in atherosclerosis.
    Colin S; Chinetti-Gbaguidi G; Staels B
    Immunol Rev; 2014 Nov; 262(1):153-66. PubMed ID: 25319333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage profiling in atherosclerosis: understanding the unstable plaque.
    Gianopoulos I; Daskalopoulou SS
    Basic Res Cardiol; 2024 Feb; 119(1):35-56. PubMed ID: 38244055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo near infrared fluorescence (NIRF) intravascular molecular imaging of inflammatory plaque, a multimodal approach to imaging of atherosclerosis.
    Calfon MA; Rosenthal A; Mallas G; Mauskapf A; Nudelman RN; Ntziachristos V; Jaffer FA
    J Vis Exp; 2011 Aug; (54):. PubMed ID: 21847078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of metabolic reprogramming of oxygen-induced macrophages in the dynamic changes of atherosclerotic plaques.
    Shen L; Chen W; Ding J; Shu G; Chen M; Zhao Z; Xia S; Ji J
    FASEB J; 2023 Mar; 37(3):e22791. PubMed ID: 36723768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity of macrophage phenotypes and responses in atherosclerosis.
    Jinnouchi H; Guo L; Sakamoto A; Torii S; Sato Y; Cornelissen A; Kuntz S; Paek KH; Fernandez R; Fuller D; Gadhoke N; Surve D; Romero M; Kolodgie FD; Virmani R; Finn AV
    Cell Mol Life Sci; 2020 May; 77(10):1919-1932. PubMed ID: 31720740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage proliferation and apoptosis in atherosclerosis.
    Andrés V; Pello OM; Silvestre-Roig C
    Curr Opin Lipidol; 2012 Oct; 23(5):429-38. PubMed ID: 22964992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of Macrophages in Atherogenesis.
    Farahi L; Sinha SK; Lusis AJ
    Front Pharmacol; 2021; 12():785220. PubMed ID: 34899348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage subsets in atherosclerosis.
    Chinetti-Gbaguidi G; Colin S; Staels B
    Nat Rev Cardiol; 2015 Jan; 12(1):10-7. PubMed ID: 25367649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin as a potential modulator of M1 and M2 macrophages: new insights in atherosclerosis therapy.
    Momtazi-Borojeni AA; Abdollahi E; Nikfar B; Chaichian S; Ekhlasi-Hundrieser M
    Heart Fail Rev; 2019 May; 24(3):399-409. PubMed ID: 30673930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular Macrophages in Atherosclerosis.
    Xu H; Jiang J; Chen W; Li W; Chen Z
    J Immunol Res; 2019; 2019():4354786. PubMed ID: 31886303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Macrophage Phenotypes and Metabolism as Novel Therapeutic Approaches in Atherosclerosis and Related Cardiovascular Diseases.
    Wang J; Wu Q; Wang X; Liu H; Chen M; Xu L; Zhang Z; Li K; Li W; Zhong J
    Curr Atheroscler Rep; 2024 Oct; 26(10):573-588. PubMed ID: 39133247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shear stress-induced atherosclerotic plaque composition in ApoE(-/-) mice is modulated by connexin37.
    Pfenniger A; Meens MJ; Pedrigi RM; Foglia B; Sutter E; Pelli G; Rochemont V; Petrova TV; Krams R; Kwak BR
    Atherosclerosis; 2015 Nov; 243(1):1-10. PubMed ID: 26342936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophages in atherosclerosis: a dynamic balance.
    Moore KJ; Sheedy FJ; Fisher EA
    Nat Rev Immunol; 2013 Oct; 13(10):709-21. PubMed ID: 23995626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic deletion or TWEAK blocking antibody administration reduce atherosclerosis and enhance plaque stability in mice.
    Sastre C; Fernández-Laso V; Madrigal-Matute J; Muñoz-García B; Moreno JA; Pastor-Vargas C; Llamas-Granda P; Burkly LC; Egido J; Martín-Ventura JL; Blanco-Colio LM
    J Cell Mol Med; 2014 Apr; 18(4):721-34. PubMed ID: 24479820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage metabolic reprogramming and atherosclerotic plaque microenvironment: Fostering each other?
    Xiao Q; Hou R; Xie L; Niu M; Pan X; Zhu X
    Clin Transl Med; 2023 May; 13(5):e1257. PubMed ID: 37151159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT6 Upregulation Promotes M2 Macrophage Polarization to Suppress Atherosclerosis.
    Gong M; Zhuo X; Ma A
    Med Sci Monit Basic Res; 2017 Jun; 23():240-249. PubMed ID: 28615615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage-mediated proteolytic remodeling of the extracellular matrix in atherosclerosis results in neoepitopes: a potential new class of biochemical markers.
    Skjøt-Arkil H; Barascuk N; Register T; Karsdal MA
    Assay Drug Dev Technol; 2010 Oct; 8(5):542-52. PubMed ID: 20662734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A lipid-structured model for macrophage populations in atherosclerotic plaques.
    Ford HZ; Byrne HM; Myerscough MR
    J Theor Biol; 2019 Oct; 479():48-63. PubMed ID: 31319051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.